GL1X · GenesisL1 explorer

Research workbench

Human insulin degrading enzyme E111Q in complex with inhibitor compound 41367

Analyse Human insulin degrading enzyme E111Q in complex with inhibitor compound 41367 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2YPU
Type
protein
Length
1,910 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin-degrading enzyme
EC
3.4.24.56
UniProt
P14735
Ligands
I41, ZN
Pockets
20 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInsulin-degrading enzyme (EC 3.4.24.56)protein95644% helix, 20% strandP14735
BInsulin-degrading enzyme (EC 3.4.24.56)protein95445% helix, 20% strandP14735

Ligands and binding sites

  • I41 · 2-[[2-[[(2S)-3-(3H-imidazol-4-yl)-1-methoxy-1-oxo-propan-2-yl]amino]-2-oxo-ethyl]-(phenylmethyl)amino]ethanoic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 12 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110220.850.8699empty
28450.750.79117ZN
37120.720.7995empty
45080.700.8072empty
53500.660.8143empty

Interfaces

1 interface between chains.

  • A–B · 1578 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 2YPU · human insulin degrading enzyme E111Q in complex with inhibitor compound 41367 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.